The life sciences sector in the United Kingdom is encountering significant challenges as new reforms regarding the National Health Service (NHS) drug evaluation process come into effect. Johan Kahlstrom, the
All posts tagged in Novartis
2Articles
Britain faces a growing crisis in its life sciences sector as a senior executive at Novartis has declared the UK “uninvestable” owing to stringent and outdated drug pricing policies. Johan
